16
22
22
Biosimilar Red Tape Elimination Act
10/18/2025, 8:05 AM
Summary of Bill HR 5526
H.R. 5526, introduced in the 119th Congress on September 19, 2025, aims to enhance the standards for determining the interchangeability of a biological product with its reference product.
Read the Full Bill
Current Status of Bill HR 5526
Bill HR 5526 is currently in the status of Bill Introduced since September 19, 2025. Bill HR 5526 was introduced during Congress 119 and was introduced to the House on September 19, 2025. Bill HR 5526's most recent activity was Referred to the House Committee on Energy and Commerce. as of September 19, 2025
Bipartisan Support of Bill HR 5526
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
3Democrat Cosponsors
3Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 5526
Primary Policy Focus
Alternate Title(s) of Bill HR 5526
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
Comments
Sponsors and Cosponsors of HR 5526
Latest Bills
Capping Appointed Positions Act
Bill HR 9714July 27, 2026
Wildfire Prevention and Recovery Act
Bill S 4970July 27, 2026
Drug Deal Disclosure Act
Bill HR 9699July 27, 2026
Stop PRC Economic Espionage Act of 2026
Bill S 5024July 27, 2026
Child Marriage Prevention Act of 2026
Bill HR 9758July 27, 2026
Improving Access to Transfusion Care for Hospice Patients Act of 2026
Bill HR 9703July 27, 2026
Mamas First Act
Bill HR 9712July 27, 2026
Protecting Americans’ Health Care Act of 2026
Bill HR 9623July 27, 2026
Ratepayer Protection Act
Bill S 5028July 27, 2026
Disaster Communications Coordination and Preparedness Act
Bill S 4691July 27, 2026